Release of Wolbachia-infected male mosquitoes reduced dengue risk by 71-72% in Singapore trial
This cluster-randomized trial with test-negative controls, conducted in Singapore, evaluated whether releasing male Aedes aegypti mosquitoes infected with the AlbB strain of Wolbachia bacteria could suppress wild mosquito populations and reduce dengue virus infection risk. The trial divided 15 geographic clusters into two groups: 8 intervention clusters received deployments of the Wolbachia-infected male mosquitoes, and 7 control clusters received no deployments. A total of 393,236 residents lived in the intervention clusters and 331,192 in the control clusters. The primary endpoint was the diagnosis of symptomatic dengue virus infection of any severity caused by any serotype, measured by the odds ratio for Wolbachia exposure among laboratory-confirmed dengue cases compared with test-negative controls. The intervention successfully suppressed adult wild-type Aedes aegypti populations. The baseline average abundance of adult female mosquitoes (number trapped divided by number of traps) was 0.18 in intervention clusters and 0.19 in control clusters. From 3 months after intervention initiation until the end of the 24-month trial period, the average abundance was 0.041 in intervention clusters and 0.277 in control clusters. In the intention-to-treat analysis at 6 months or more, the percentage of residents in intervention clusters who were dengue-positive was lower than in control clusters (354 of 5722 tests [6%] vs. 1519 of 7080 tests [21%]). The protective efficacy of the intervention, calculated as (1 - odds ratio) × 100, ranged from 71% to 72% with 3 to 12 months or more of Wolbachia mosquito exposure, as represented by odds ratios of 0.28 to 0.29. The trial was funded by the Singapore Ministry of Finance and others.